达芬奇单端口(SP)机器人平台在泌尿外科的应用:系统的文献综述。

Q1 Medicine
M. Moschovas, S. Bhat, T. Rogers, D. Thiel, F. Onol, S. Roof, M. Sighinolfi, B. Rocco, V. Patel
{"title":"达芬奇单端口(SP)机器人平台在泌尿外科的应用:系统的文献综述。","authors":"M. Moschovas, S. Bhat, T. Rogers, D. Thiel, F. Onol, S. Roof, M. Sighinolfi, B. Rocco, V. Patel","doi":"10.23736/S0393-2249.20.03899-0","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nRobotic surgical technology has evolved to include a new platform specifically designed for the single-port (SP) approach. Benefits of the Da Vinci SP are still under investigation. This study aimed to review the urological literature since the first report of the use of the platform.\n\n\nEVIDENCE ACQUISITION\nWe performed a systematic literature review of PubMed, Medline, and Web of Science databases on June 15th, 2020 searching for all available articles of da Vinci SP use from December 2014 (date of the first clinical report of da Vinci SP in the urology) until June 1st, 2020 following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.\n\n\nEVIDENCE SYNTHESIS\nA total of 43 articles were eligible for inclusion. Ten studies reported different surgeries and techniques on cadavers while the rest described the clinical experience of different groups. We divided our article and tables into pre-clinical experience with surgery on cadavers, radical prostatectomy (RP) approach, and multiple types of procedures described in the same study.\n\n\nCONCLUSIONS\nThe application of da Vinci SP in urologic procedures after five yearsof the first clinical investigation is feasible and safe. Radical prostatectomy is the most common intervention performed with this robot. Some groups described benefits in terms of less postoperative pain and early discharge, especially with the extraperitoneal approach. However, further studies with larger sample sizes and longer follow-up are awaited.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"178 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":"{\"title\":\"Applications of the da Vinci Single Port (SP) robotic platform in urology: a systematic literature review.\",\"authors\":\"M. Moschovas, S. Bhat, T. Rogers, D. Thiel, F. Onol, S. Roof, M. Sighinolfi, B. Rocco, V. Patel\",\"doi\":\"10.23736/S0393-2249.20.03899-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION\\nRobotic surgical technology has evolved to include a new platform specifically designed for the single-port (SP) approach. Benefits of the Da Vinci SP are still under investigation. This study aimed to review the urological literature since the first report of the use of the platform.\\n\\n\\nEVIDENCE ACQUISITION\\nWe performed a systematic literature review of PubMed, Medline, and Web of Science databases on June 15th, 2020 searching for all available articles of da Vinci SP use from December 2014 (date of the first clinical report of da Vinci SP in the urology) until June 1st, 2020 following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.\\n\\n\\nEVIDENCE SYNTHESIS\\nA total of 43 articles were eligible for inclusion. Ten studies reported different surgeries and techniques on cadavers while the rest described the clinical experience of different groups. We divided our article and tables into pre-clinical experience with surgery on cadavers, radical prostatectomy (RP) approach, and multiple types of procedures described in the same study.\\n\\n\\nCONCLUSIONS\\nThe application of da Vinci SP in urologic procedures after five yearsof the first clinical investigation is feasible and safe. Radical prostatectomy is the most common intervention performed with this robot. Some groups described benefits in terms of less postoperative pain and early discharge, especially with the extraperitoneal approach. However, further studies with larger sample sizes and longer follow-up are awaited.\",\"PeriodicalId\":49015,\"journal\":{\"name\":\"Minerva Urologica E Nefrologica\",\"volume\":\"178 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Urologica E Nefrologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0393-2249.20.03899-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Urologica E Nefrologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0393-2249.20.03899-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 13

摘要

机器人手术技术已经发展到包括一个专门为单端口(SP)入路设计的新平台。达芬奇SP的益处仍在调查中。本研究旨在回顾自首次报道使用该平台以来的泌尿学文献。我们于2020年6月15日对PubMed、Medline和Web of Science数据库进行了系统的文献综述,根据系统评价和荟萃分析(PRISMA)指南的首选报告项目,检索了2014年12月(达芬奇SP在泌尿科首次临床报告的日期)至2020年6月1日期间所有可用的达芬奇SP使用文章。总共有43篇文章符合纳入条件。10项研究报告了不同的尸体手术和技术,其余研究描述了不同群体的临床经验。我们将文章和表格分为尸体手术的临床前经验,根治性前列腺切除术(RP)方法,以及同一研究中描述的多种类型的手术。结论经过5年的首次临床研究,达芬奇SP在泌尿外科手术中的应用是可行和安全的。根治性前列腺切除术是该机器人最常用的干预手段。一些小组描述了术后疼痛减少和早期出院的好处,特别是腹腔外入路。然而,更大的样本量和更长的随访时间有待进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Applications of the da Vinci Single Port (SP) robotic platform in urology: a systematic literature review.
INTRODUCTION Robotic surgical technology has evolved to include a new platform specifically designed for the single-port (SP) approach. Benefits of the Da Vinci SP are still under investigation. This study aimed to review the urological literature since the first report of the use of the platform. EVIDENCE ACQUISITION We performed a systematic literature review of PubMed, Medline, and Web of Science databases on June 15th, 2020 searching for all available articles of da Vinci SP use from December 2014 (date of the first clinical report of da Vinci SP in the urology) until June 1st, 2020 following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. EVIDENCE SYNTHESIS A total of 43 articles were eligible for inclusion. Ten studies reported different surgeries and techniques on cadavers while the rest described the clinical experience of different groups. We divided our article and tables into pre-clinical experience with surgery on cadavers, radical prostatectomy (RP) approach, and multiple types of procedures described in the same study. CONCLUSIONS The application of da Vinci SP in urologic procedures after five yearsof the first clinical investigation is feasible and safe. Radical prostatectomy is the most common intervention performed with this robot. Some groups described benefits in terms of less postoperative pain and early discharge, especially with the extraperitoneal approach. However, further studies with larger sample sizes and longer follow-up are awaited.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Minerva Urologica E Nefrologica
Minerva Urologica E Nefrologica UROLOGY & NEPHROLOGY-
CiteScore
5.50
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: The journal Minerva Urologica e Nefrologica publishes scientific papers on nephrology and urology. Manuscripts may be submitted in the form of Minerva opinion editorials, editorial comments, original articles, video illustrated articles, review articles and letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信